✦ LIBER ✦

Receipt of adjuvant breast cancer therapy in minority women : The type of treatment center matters

✍ Scribed by Sophia Edwards-Bennett

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 62 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26326

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reply to receipt of adjuvant breast canc

Reply to receipt of adjuvant breast cancer therapy in minority women

✍ Rachel A. Freedman; Nancy L. Keating 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 1 views

The role of aromatase inhibitors in the

The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma : The M. D. Anderson Cancer Center evidence-based approach

✍ Paolo Morandi; Roman Rouzier; Kadri Altundag; Aman U. Buzdar; Richard L. Theriau 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

## Abstract ## BACKGROUND The authors examined the published evidence on the use of aromatase inhibitors (AIs) in the adjuvant setting in postmenopausal, hormone receptor–positive patients, and they provide recommendations for clinical management in 3 different situations: newly diagnosed women, w

Clinical update: Impact of Adjuvant Ther

Clinical update: Impact of Adjuvant Therapy on Quality of Life in Women with Node Positive Operable Breast Cancer. Hurny, C., Bernhard, J., Coates, A.S., Castiglione-Gertsch, M., Peterson, H.F. et al. for the International Breast Cancer Study Group (1996) 347, No. 9011, 1279–1284.

✍ William Breitbart; Ann Cull; Donna Greenberg 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

Anastrozole alone or in combination with

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer : Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses

✍ The ATAC (Arimidex; Tamoxifen Alone or in Combination) Trialists' Group 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

## Abstract ## BACKGROUND The first analysis of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial (median follow‐up, 33 months) demonstrated that in adjuvant endocrine therapy for postmenopausal patients with early‐stage breast cancer, anastrozole was superior to tamoxifen in terms of d

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views